{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T12:42:56Z","timestamp":1745757776184},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,14]],"date-time":"2009-07-14T00:00:00Z","timestamp":1247529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s11936-009-0031-7","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T03:39:23Z","timestamp":1247456363000},"page":"305-315","source":"Crossref","is-referenced-by-count":2,"title":["Sociology meets genetics: Sociogenetic implications for future management of hypertension and heart failure"],"prefix":"10.1007","volume":"11","author":[{"given":"Randy","family":"Wexler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Pleister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,14]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archinte.167.14.1460","volume":"167","author":"B.D. Dickinson","year":"2007","unstructured":"Dickinson BD, Havas S: Reducing the population burden of cardiovascular disease by reducing sodium intake. Arch Intern Med 2007, 167:1460\u20131468.","journal-title":"Arch Intern Med"},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/jn.108.098269","volume":"139","author":"J. Li","year":"2009","unstructured":"Li J, White J, Guo L, et al.: Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 2009, 139:1\u20135.","journal-title":"J Nutr"},{"key":"31_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.HYP.35.1.38","volume":"35","author":"R. Gros","year":"2000","unstructured":"Gros R, Chorazyczewski J, Meek MD, et al.: GRK activity in hypertension, increased vascular and lymphocyte GRK-2 protein expression. Hypertension 2000, 35:38\u201342.","journal-title":"Hypertension"},{"key":"31_CR4","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1172\/JCI119381","volume":"99","author":"R. Gros","year":"1997","unstructured":"Gros R, Benovic JL, Tan CM, Feldman RD: G-protein coupled receptor kinase activity is increased in hypertension. J Clin Invest 1997, 99:2087\u20132093.","journal-title":"J Clin Invest"},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehi429","volume":"26","author":"G. Iaccarino","year":"2005","unstructured":"Iaccarino G, Barbato E, Cipoletta E, et al.: Elevated myocardial and lymphocyte GRK-2 expression and activity in human heart failure. Eur Heart J 2005, 26:1752\u20131758.","journal-title":"Eur Heart J"},{"key":"31_CR6","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"A. Chobanian","year":"2003","unstructured":"Chobanian A, Bakris G, Black H, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Management of High Blood Pressure (JNC-7). Hypertension 2003, 42:1206\u20131252.","journal-title":"Hypertension"},{"key":"31_CR7","volume-title":"Heart Disease and Stroke Statistics\u20142004 Update","author":"American Heart Association","year":"2003","unstructured":"American Heart Association: Heart Disease and Stroke Statistics\u20142004 Update. Dallas, TX: American Heart Association; 2003."},{"key":"31_CR8","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","volume":"362","author":"F. Turnbull","year":"2003","unstructured":"Turnbull F; Blood Pressure Lowering Treatment Trialists\u2019 Collaboration: Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003, 362:1527\u20131535.","journal-title":"Lancet"},{"key":"31_CR9","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S. Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, et al.: Age specific relevance of usual blood pressure to vascular mortality: a meta analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903\u20131913.","journal-title":"Lancet"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","volume":"115","author":"W. Rosamond","year":"2007","unstructured":"Rosamond W, Flegal K, Friday G, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69\u2013e171.","journal-title":"Circulation"},{"key":"31_CR11","unstructured":"Levit K, Stranges E, Ryan K, Elixhauser A: HCUP facts and figures, 2006: statistics on hospital-based care in the United States. Available at http:\/\/www.hcup-us.ahrq.gov\/reports.jsp . Accessed May 2009."},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/jech.2005.044255","volume":"60","author":"M.A. Denvir","year":"2006","unstructured":"Denvir MA, Lee AJ, Rysdale J, et al.: Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention. J Epidemiol Community Health 2006, 60:1085\u20131088.","journal-title":"J Epidemiol Community Health"},{"key":"31_CR13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2105\/AJPH.2005.069443","volume":"97","author":"A. Brown","year":"2007","unstructured":"Brown A, Ang A, Pebley AR: The relationship between characteristics of self related health for adults with chronic conditions. Am J Public Health 2007, 97:926\u2013932.","journal-title":"Am J Public Health"},{"key":"31_CR14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.HYP.13.5_Suppl.I94","volume":"13","author":"H.A. Tyroler","year":"1989","unstructured":"Tyroler HA: Socioeconomic status in the epidemiology and treatment of hypertension. Hypertension 1989, 13:194\u2013197.","journal-title":"Hypertension"},{"key":"31_CR15","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"S.A. Hunt","year":"2005","unstructured":"Hunt SA, Abraham WT, Chin MH, et al.; American College of Cardiology American Heart Association Task Force on Practice Guidelines American College of Chest Physicians International Society for Heart and Lung Transplantation Heart Rhythm Society: ACC\/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154\u2013e235.","journal-title":"Circulation"},{"key":"31_CR16","first-page":"2083","volume":"289","author":"L.J. Appel","year":"2003","unstructured":"Appel LJ, Champagne CM, Harsha DW; PREMIER Collaborative Research Writing Group: Effects of comprehensive lifestyle modification on blood pressure control. JAMA 2003, 289:2083\u20132093.","journal-title":"JAMA"},{"key":"31_CR17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.39147.604896.55","volume":"334","author":"N.R. Cook","year":"2007","unstructured":"Cook NR, Cutler JA, Obarzanek E, et al.: Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trial of hypertension prevention (TOHP). BMJ 2007, 334:885.","journal-title":"BMJ"},{"key":"31_CR18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.7326\/0003-4819-135-12-200112180-00005","volume":"135","author":"W. Vollmer","year":"2001","unstructured":"Vollmer W, Sacks F, Ard J, et al.: Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med 2001, 135:1019\u20131028.","journal-title":"Ann Intern Med"},{"key":"31_CR19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.RES.74.2.206","volume":"74","author":"M. Ungerer","year":"1994","unstructured":"Ungerer M, Parruti G, B\u00f6hm M, et al.: Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 1994, 74:206\u2013213.","journal-title":"Circ Res"},{"key":"31_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/ajcn.2008.26856","volume":"89","author":"K.M. Dickinson","year":"2009","unstructured":"Dickinson KM, Keogh JB, Clifton PM: Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 2009, 89:1\u20136.","journal-title":"Am J Clin Nutr"},{"key":"31_CR21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3121\/cmr.2007.737","volume":"4","author":"S. Alsafwah","year":"2007","unstructured":"Alsafwah S, LaGuarida SP, Arroyo M, et al.: Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res 2007, 4:238\u2013243.","journal-title":"Clin Med Res"},{"key":"31_CR22","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.188965","volume":"117","author":"D.D. Schocken","year":"2008","unstructured":"Schocken DD, Benjamin EJ, Fonarow GC, et al.: Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology, Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008, 117:2544\u20132565.","journal-title":"Circulation"},{"key":"31_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0884533608314533","volume":"23","author":"C.M. Champagne","year":"2008","unstructured":"Champagne CM: Magnesium and hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Pract 2008, 23:142\u2013151.","journal-title":"Nutr Clin Pract"},{"key":"31_CR24","unstructured":"Lexi-Comp website. Available at http:\/\/www.lexi.com\/home . Accessed May 2009."},{"key":"31_CR25","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"G. Garg","year":"1995","unstructured":"Garg G, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995, 273:1450\u20131463.","journal-title":"JAMA"},{"key":"31_CR26","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/01.CIR.0000146819.43235.A9","volume":"110","author":"J.B. Young","year":"2004","unstructured":"Young JB, Dunlap ME, Pfeffer MA, et al.: Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation 2004, 110:2618\u20132626.","journal-title":"Circulation"},{"key":"31_CR27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S. Yusuf","year":"2008","unstructured":"ONTARGET Investigators, Yusuf S, Teo KK, et al.: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008, 358:1547\u20131559.","journal-title":"N Engl J Med"},{"key":"31_CR28","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJMe0801925","volume":"358","author":"J.V. McMurray","year":"2008","unstructured":"McMurray JV: ACE inhibitors in cardiovascular disease\u2014unbeatable? N Engl J Med 2008, 358:1615\u20131616.","journal-title":"N Engl J Med"},{"key":"31_CR29","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M. Packer","year":"2001","unstructured":"Packer M, Coats A, Fowler MB, et al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651\u20131658.","journal-title":"N Engl J Med"},{"key":"31_CR30","doi-asserted-by":"crossref","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999, 353:2001\u20132007.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"31_CR31","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"The ALLHAT OfficersCoordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981\u20132997.","journal-title":"JAMA"},{"key":"31_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","volume":"15","author":"B. Pitt","year":"2001","unstructured":"Pitt B, Williams G, Remme W, et al.: The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction: Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 2001, 15:79\u201387.","journal-title":"Cardiovasc Drugs Ther"},{"key":"31_CR33","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1161\/01.CIR.0000132477.32438.03","volume":"109","author":"S.H. Rahimtoola","year":"2004","unstructured":"Rahimtoola SH: Digitalis therapy for patients in clinical heart failure. Circulation 2004, 109:2942\u20132946.","journal-title":"Circulation"},{"key":"31_CR34","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","volume":"292","author":"S.E. Nissen","year":"2004","unstructured":"Nissen SE, Tuzcu EM, Libby P, et al.: Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004, 292:2217\u20132226.","journal-title":"JAMA"},{"key":"31_CR35","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K. Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, et al.: Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008, 359:2417\u20132428.","journal-title":"N Engl J Med"},{"key":"31_CR36","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","volume":"351","author":"A.L. Taylor","year":"2004","unstructured":"Taylor AL, Ziesche S, Yancy C, et al.; for the African-American Heart Failure Trial Investigators: Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004, 351:2049\u20132057.","journal-title":"N Engl J Med"},{"key":"31_CR37","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","volume":"292","author":"A.S. Desai","year":"2004","unstructured":"Desai AS, Fang JC, Maisel WH, et al.: Implantable defibrillators for the prevention of mortality in patients with non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 2004, 292:2874\u20132879.","journal-title":"JAMA"},{"key":"31_CR38","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"A.J. Moss","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877\u2013883.","journal-title":"N Engl J Med"},{"key":"31_CR39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/01.CIR.79.4.845","volume":"79","author":"C.L. Grines","year":"1989","unstructured":"Grines CL, Bashore TM, Boudolas H, et al.: Functional abnormalities in isolated left bundle branch bloc: the effect of interventricular asynchrony. Circulation 1989, 79:845\u2013853.","journal-title":"Circulation"},{"key":"31_CR40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/hrt.66.6.443","volume":"66","author":"H.B. Xiao","year":"1991","unstructured":"Xiao HB, Lee CH, Gibson DG: Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 1991, 66:443\u2013447.","journal-title":"Br Heart J"},{"key":"31_CR41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9149(84)90320-5","volume":"54","author":"D.V. Unverforth","year":"1989","unstructured":"Unverforth DV, Magorien RD, Moeschberger ML, et al.: Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1989, 54:147\u2013152.","journal-title":"Am J Cardiol"},{"key":"31_CR42","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1161\/01.CIR.0000096580.26969.9A","volume":"108","author":"W.T. Abraham","year":"2003","unstructured":"Abraham WT, Hayes DL: Cardiac resynchronization therapy for heart failure. Circulation 2003, 108:2596\u20132603.","journal-title":"Circulation"},{"key":"31_CR43","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1161\/01.CIR.0000124479.89015.64","volume":"109","author":"J.-J. Blanc","year":"2004","unstructured":"Blanc J-J, Bertault-Valls V, Fatemi M, et al.: Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation 2004, 109:1741\u20131744.","journal-title":"Circulation"},{"key":"31_CR44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jama.289.6.730","volume":"289","author":"D.J. Bradley","year":"2003","unstructured":"Bradley DJ, Bradley EA, Baughman KL, et al.: Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003, 289:730\u2013740.","journal-title":"JAMA"},{"key":"31_CR45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2003.10.002","volume":"93","author":"T.V. Salukhe","year":"2004","unstructured":"Salukhe TV, Dimopoulos K, Francis D: Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC [editorial]. Int J Cardiol 2004, 93:101\u2013103.","journal-title":"Int J Cardiol"},{"key":"31_CR46","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"M.R. Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140\u20132150.","journal-title":"N Engl J Med"},{"key":"31_CR47","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"J.G. Cleland","year":"2005","unstructured":"Cleland JG, Daubert JC, Erdmann E, et al.; the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539\u20131549.","journal-title":"N Engl J Med"},{"key":"31_CR48","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.athoracsur.2008.06.030","volume":"86","author":"R. John","year":"2008","unstructured":"John R, Kamdar F, Liao K, et al.: Improved survival and decreasing incidence of adverse events with HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008, 86:1227\u20131234.","journal-title":"Ann Thorac Surg"},{"key":"31_CR49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2105\/AJPH.88.3.389","volume":"88","author":"J.W. Lynch","year":"1998","unstructured":"Lynch JW, Everson SA, Kaplan GA, et al.: Does low socioeconomic status potentiate the effects of heightened cardiovascular responses to stress on the progression of carotid atherosclerosis? Am J Public Health 1998, 88:389\u2013394.","journal-title":"Am J Public Health"},{"key":"31_CR50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF03215777","volume":"1","author":"J.R. Betancourt","year":"1999","unstructured":"Betancourt JR, Carrillo JE, Green AR: Hypertension in multicultural and minority populations: linking communication to compliance. Curr Hypertens Rep 1999, 1:482\u2013488.","journal-title":"Curr Hypertens Rep"},{"key":"31_CR51","doi-asserted-by":"crossref","unstructured":"Wexler RK, Elton T, Pleister A, Feldman DS: Barriers to blood pressure control as reported by African-American patients. J Natl Med Assoc 2009 (in press).","DOI":"10.1016\/S0027-9684(15)30947-0"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-009-0031-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-009-0031-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-009-0031-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:35Z","timestamp":1559422595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-009-0031-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,14]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s11936-009-0031-7","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,14]]}}}